ResearcherTokushima UniversityNo recent work listed
Shuichi Iwahashi
Matched on OpenAlex author ID A5113646547. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers
Papers 3
- Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer. Co-author DOI 10.1007/s10147-013-0529-6↗
- Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines. Last author PMID 24982347↗
- Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells. Co-author DOI 10.1007/s10147-011-0246-y↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tetsuya Ikemoto · 3 shared papers, 2011–2014 · strength 0.12
- Paper Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines. PMID 24982347↗
- Paper Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients wi… DOI 10.1007/s10147-013-0529-6↗
- Paper Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer… DOI 10.1007/s10147-011-0246-y↗
- Mitsuo Shimada · 3 shared papers, 2011–2014 · strength 0.12
- Paper Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines. PMID 24982347↗
- Paper Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients wi… DOI 10.1007/s10147-013-0529-6↗
- Paper Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer… DOI 10.1007/s10147-011-0246-y↗
- Koji Sugimoto · 2 shared papers, 2011–2014 · strength 0.07
- Tohru Utsunomiya · 2 shared papers, 2011–2014 · strength 0.07
- Paper Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients wi… DOI 10.1007/s10147-013-0529-6↗
- Paper Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer… DOI 10.1007/s10147-011-0246-y↗
- Yu Saito · 2 shared papers, 2011–2014 · strength 0.07
- Paper Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients wi… DOI 10.1007/s10147-013-0529-6↗
- Paper Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer… DOI 10.1007/s10147-011-0246-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.